Norway
· Delayed Price · Currency is NOK Lytix Biopharma AS Statistics
Total Valuation
OSL:LYTIX has a market cap or net worth of NOK 333.80 million. The enterprise value is 205.65 million.
| Market Cap | 333.80M |
| Enterprise Value | 205.65M |
Important Dates
The next estimated earnings date is Thursday, April 10, 2025.
| Earnings Date | Apr 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:LYTIX has 68.26 million shares outstanding. The number of shares has increased by 35.10% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 68.26M |
| Shares Change (YoY) | +35.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 13.41% |
| Float | 34.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.78 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.18 |
| EV / Sales | 18.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.91 |
| Quick Ratio | 3.91 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -173.41 |
Financial Efficiency
Return on equity (ROE) is -118.41% and return on invested capital (ROIC) is -73.84%.
| Return on Equity (ROE) | -118.41% |
| Return on Assets (ROA) | -56.97% |
| Return on Invested Capital (ROIC) | -73.84% |
| Return on Capital Employed (ROCE) | -87.36% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | -11.78M |
| Employee Count | 8 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.84% in the last 52 weeks. The beta is -0.63, so OSL:LYTIX's price volatility has been lower than the market average.
| Beta (5Y) | -0.63 |
| 52-Week Price Change | -19.84% |
| 50-Day Moving Average | 5.29 |
| 200-Day Moving Average | 7.17 |
| Relative Strength Index (RSI) | 39.72 |
| Average Volume (20 Days) | 46,734 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:LYTIX had revenue of NOK 11.13 million and -94.27 million in losses. Loss per share was -1.74.
| Revenue | 11.13M |
| Gross Profit | 11.13M |
| Operating Income | -95.90M |
| Pretax Income | -94.27M |
| Net Income | -94.27M |
| EBITDA | -95.83M |
| EBIT | -95.90M |
| Loss Per Share | -1.74 |
Balance Sheet
The company has 130.79 million in cash and 2.64 million in debt, giving a net cash position of 128.15 million or 1.88 per share.
| Cash & Cash Equivalents | 130.79M |
| Total Debt | 2.64M |
| Net Cash | 128.15M |
| Net Cash Per Share | 1.88 |
| Equity (Book Value) | 107.89M |
| Book Value Per Share | 1.58 |
| Working Capital | 107.14M |
Cash Flow
| Operating Cash Flow | -70.37M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -861.29% |
| Pretax Margin | -846.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:LYTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.10% |
| Shareholder Yield | -35.10% |
| Earnings Yield | -28.24% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |